Colombia vs Fiji: HIV-positive TB patients on ART (antiretroviral therapy)
Colombia
68.0%
in 2024
Fiji
66.0%
in 2024
Colombia rank
130th
Fiji rank
132nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Colombia
- Fiji
How they compare
Colombia currently reports 68.0% against 66.0% in Fiji, a difference of 2.0%.
The two have swapped places 2 times across 16 shared years of data; in 2006 it was Colombia ahead.
Colombia ranks 130th and Fiji ranks 132nd of 144 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Fiji in 2.
Head to head by decade
| Decade | Colombia | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.0% | 67.0% | 13.0% | Colombia |
| 2010s | 50.5% | 98.3% | 47.8% | Fiji |
| 2020s | 59.8% | 86.4% | 26.6% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Colombia or Fiji?
- Colombia, at 68.0% against 66.0% in Fiji as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Colombia and Fiji?
- 2.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Fiji?
- 16 years are reported by both, from 2006 to 2024.
- How do Colombia and Fiji rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Colombia ranks 130th and Fiji ranks 132nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.